NuCana PLC (NCNA)
1.49
-0.06
(-3.87%)
USD |
NASDAQ |
Nov 15, 16:00
1.49
0.00 (0.00%)
After-Hours: 20:00
NuCana Shares Outstanding: 2.246M for June 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
June 30, 2024 | 2.246M |
March 31, 2024 | 2.246M |
December 31, 2023 | 2.094M |
September 30, 2023 | 2.092M |
June 30, 2023 | 2.076M |
March 31, 2023 | 2.076M |
December 31, 2022 | 2.075M |
September 30, 2022 | 2.088M |
June 30, 2022 | 2.088M |
March 31, 2022 | 2.088M |
December 31, 2021 | 2.087M |
September 30, 2021 | 2.087M |
June 30, 2021 | 2.086M |
March 31, 2021 | 2.086M |
December 31, 2020 | 2.047M |
September 30, 2020 | 2.047M |
Date | Value |
---|---|
September 21, 2020 | 2.047M |
September 16, 2020 | 1.331M |
June 30, 2020 | 1.318M |
March 31, 2020 | 1.299M |
December 31, 2019 | 1.299M |
September 30, 2019 | 1.298M |
June 30, 2019 | 1.290M |
March 31, 2019 | 1.289M |
December 31, 2018 | 1.289M |
September 30, 2018 | 1.287M |
August 31, 2018 | 1.287M |
June 30, 2018 | 1.272M |
December 31, 2017 | 1.272M |
September 28, 2017 | 1.235M |
September 18, 2017 | 1.235M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.299M
Minimum
Dec 31 2019
2.246M
Maximum
Mar 31 2024
1.948M
Average
2.086M
Median
Mar 31 2021
Shares Outstanding Benchmarks
Adaptimmune Therapeutics PLC | 255.88M |
Biodexa Pharmaceuticals PLC | 0.5808M |
Autolus Therapeutics PLC | 266.09M |
Mereo BioPharma Group PLC | 155.15M |
Bicycle Therapeutics PLC | 69.05M |